share_log
Reuters ·  02:05
Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination With Keytruda for Stage Iiib/IV Non-Small Cell Lung Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment